| Literature DB >> 16412248 |
Debra McLaggan1, Noppadon Adjimatera, Kristina Sepcić, Marcel Jaspars, David J MacEwan, Ian S Blagbrough, Roderick H Scott.
Abstract
Entities:
Mesh:
Substances:
Year: 2006 PMID: 16412248 PMCID: PMC1361793 DOI: 10.1186/1472-6750-6-6
Source DB: PubMed Journal: BMC Biotechnol ISSN: 1472-6750 Impact factor: 2.563
Figure 1Structures of transfection reagents and other related molecules of interest. A, polymeric alkylpyridinium salt (poly-APS) a sponge toxin preparation composed of a mixture of two polymeric 1,3-octylpyridinium salts of 5.5 (n = 29 average) and 19 kDa (n = 99 average) sizes. B, N4,N9-dioleoylspermine (LipoGen).
Figure 2DNA condensation profile of poly APS and LipoGen using different DNA; pEGFP (4.7 kilobase pairs), pGL3 (5.3 kilobase pairs) and calf thymus DNA (13 kilobase pairs), using ethidium bromide displacement and light scattering assays. Ethidium bromide assay shows a decrease of fluorescence intensity (excitation at 260 nm, and emission at 600 nm) when poly-APS (A) or LipoGen (B) concentration was increased, expressed in a mole ratio of ammonium/DNA phosphate (N/P). Both poly-APS (4.1–4.7 μg/ml) and LipoGen (3.3–5.5 μg /ml) condense DNA efficiently with 10% residual fluorescence at N/P ratios 3.5 – 4.0 and (N/P) 1.5 – 2.5 respectively, (n = 3 for all experiments, error bars represent standard deviation). Light scattering confirmed that cationic vector-DNA complexes were formed, (C) for poly-APS, (D) for LipoGen, as the apparent absorbance at 320 nm increases significantly from the DNA only control solution.
Figure 3Records of fura-2 Ca2+ imaging. A, average (mean; n = 30 HEK 293 cells) trace showing that LipoGen (1 μg/ml) failed to cause a rise in intracellular Ca2+ but that polymeric alkylpyridinium salt (Poly-APS; 1 μg/ml) increased intracellular Ca2+ measured as a change in fluorescence ratio (Fl.R). The rise in intracellular Ca2+ was indicative of pore formation. Inset record shows a trace of changes in intracellular Ca2+ from a single cell. B, average (mean; n = 19 HEK 293 cells) trace showing that lipofectamine (1 μg/ml) failed to cause a rise in intracellular Ca2+ but that polymeric alkylpyridinium salt (Poly-APS; 1 μg/ml) increased intracellular Ca2+, indicative of pore formation. Inset record shows a trace of changes in intracellular Ca2+ from a single cell. C, single cell trace of a Ca2+ transient evoked at 12°C by poly-APS.
Figure 4Temperature sensitivity of poly-APS actions. A, dose/response relationship for poly-APS-evoked Ca2+ transients at room temperature (21°C, filled squares) and at 12°C (filled triangles). At each concentration of poly-APS, larger responses were obtained at the lower temperature. The different n values reflect variable sensitivities of HEK 293 cells to poly-APS with cells being more sensitive at lower temperatures. B, an example record showing larger increases in intracellular Ca2+ (Fl.R Fluorescence Ratio units) in response to poly-APS at 12°C compared with 21°C.
Figure 5Temperature effects were also seen when poly-APS was used for intracellular delivery of lucifer yellow. In the absence of poly-APS no intracellular uptake of lucifer yellow was observed over a 3 h incubation period. After incubation with poly-APS and lucifer yellow (1 mM) for 3 h at 21°C a few individual cells were loaded (A), but after incubation at 7°C almost all cells are filled with lucifer yellow (B). Lipofectamine and LipoGen did not deliver lucifer yellow efficiently. Merged transmission and fluorescence images show that a very modest amount of fluorescence was observed after incubation with lipofectamine and lucifer yellow (1 mM) for 3 h at 21°C (C) and no cells were loaded at 7°C (D). Similarly, with LipoGen, little fluorescence was seen after incubation at 21°C (E) and no cells were loaded at 7°C (F).
Figure 6Effect of temperature on gene delivery. A, confocal image showing expression of enhanced green fluorescent protein in HEK 293 cells after transfection at 12°C with poly-APS (0.5 μg/ml; 2.5 μg pEGFP). B, fluorescence microscope image showing expression of enhanced green fluorescent protein in HEK 293 cells after transfection at 12°C with lipofectamine (4 μg/200 μl; 1 μg pEGFP). After incubation at 12°C for cDNA delivery, cells were returned to standard culture media and conditions and incubated at 37°C for 24 h before being examined. C, Histogram showing the temperature dependence of gene delivery to HtTA HeLa cells. pEGFP DNA complexed with LipoGen (N/P ratio 2.5 and 5.0) and Lipofectamine (N/P ratio 3.0) were added into each well of HtTA HeLa cells (cervix carcinoma, 50% confluent) in serum-free media. Transfection experiments were performed at 37°C or 12°C, and then DNA complexes were removed after 4 h exposure. The number of fluorescent cells was determined by FACS cytometry after 44 h post-transfection at 37°C, to determine the efficiency of pEGFP delivery systems. Significant decrease of transfection efficiency at 12°C was found in all lipofection systems used, compared with standard transfection conditions at 37°C. (n = 3 for all transfections, three replicates each, error bars represent standard deviation).
Figure 7Delivery of siRNA with lipofectamine and LipoGen into HEK 293 cells. Intracellular delivery of siRNA fluorescein conjugate using A, lipofectamine and B, LipoGen as transfection reagents was visualised as confocal transmission images after a 4.5 h incubation period. No siRNA-positive cells were observed in the absence of a transfection reagent or after incubation with poly-APS. The left-hand images are fluorescent images and the right-hand images are corresponding transmission images.
Figure 8Delivery of β-actin siRNA using lipofectamine knocked down β-actin. A, Western blots of β-actin expression in HEK 293 cells and knockdown by delivery of β-actin siRNA using lipofectamine (Lipofect), but not poly-APS, in the absence of serum in the incubation media for 3 h and 6 h. The presence of 10 % serum has been shown to attenuate poly-APS-mediated pore formation, so experiments were conducted in serum-free conditions. B, shows a standard loading record for NFKB for the Western blots of siRNA knockdown of β-actin by LipoGen, poly-APS and lipofectamine (Lipofect) illustrated in part C of this figure. C, Western blots for siRNA knockdown of β-actin by LipoGen, lipofectamine (Lipofect) and poly-APS.
Figure 9Histogram showing normalised data for siRNA knockdown of β-actin and the effect of different transfection reagents. All data are represented as mean percentage expression relative to the control. Data analyses conducted after 24 or 48 h are included.